Should You Give Aspirin to Someone Having a Stroke?

Giving aspirin to someone you suspect is having a stroke is not recommended unless emergency medical professionals have instructed you to do so. The reason is straightforward but potentially life-saving: roughly one in six strokes involves bleeding in the brain rather than a clot, and aspirin makes bleeding worse. Because bystanders have no way to tell which type of stroke is happening, handing someone an aspirin during a suspected stroke is a gamble with serious consequences. The right move is to call emergency services immediately and let the hospital sort out whether aspirin is appropriate after a brain scan.

Two Very Different Types of Stroke

A stroke happens when part of the brain loses its blood supply, but there are two fundamentally different ways that occurs. In an ischemic stroke, a blood clot blocks an artery feeding the brain. In a hemorrhagic stroke, a blood vessel in or around the brain ruptures and bleeds. In the United States, about 83% of strokes are ischemic, while the rest are hemorrhagic, split between bleeding within the brain itself and bleeding in the surrounding membranes.¹ That roughly five-to-one ratio means most strokes are the clotting kind, but “most” is not “all,” and the hemorrhagic minority is growing. Incidence of bleeding-type strokes has risen substantially over recent decades, making the distinction more relevant than ever.

The treatments for these two stroke types are almost opposite. Ischemic strokes need therapies that dissolve or prevent clots. Hemorrhagic strokes need therapies that stop bleeding. Aspirin, which thins the blood by preventing platelets from clumping together, falls squarely into the first category. Give it during an ischemic stroke and it can help. Give it during a hemorrhagic stroke and you are pouring fuel on the fire, potentially enlarging the bleed and worsening brain damage.

Why You Cannot Tell the Difference by Looking

The cruel reality is that ischemic and hemorrhagic strokes often look the same from the outside. The classic warning signs people learn, like facial drooping, arm weakness, and slurred speech, show up in both types. A large meta-analysis pooling data from over 12 million stroke patients found that while certain symptoms were more common in one type, nothing reliably separated the two at the bedside.² Symptoms like vomiting, severe headache, and loss of consciousness were several times more common in hemorrhagic strokes, while facial weakness and weakness on one side of the body were slightly more common in ischemic strokes. But none of these signs were exclusive to either type. A person vomiting with a sudden headache could still be having an ischemic stroke. A person with one-sided weakness could still be bleeding into their brain.

Even trained emergency physicians cannot reliably distinguish ischemic from hemorrhagic stroke without imaging. The only way to know for certain is a CT scan of the brain, which is why stroke protocols universally require one before treatment decisions are made.³ If a CT scan is expected within 48 hours of symptom onset, clinical guidance says to wait for the result before starting aspirin. This is not excessive caution; it is the standard of care.

What Aspirin Actually Does During an Ischemic Stroke

When a clot blocks an artery in the brain, the damage zone tends to grow over the following hours and days. Part of that growth comes from new clots forming on top of the original one. Aspirin works against this cascade in several ways. It blocks platelet clumping at the site of the clot, reducing the chance of the blockage growing or a second clot forming elsewhere. It also interferes with chemicals that constrict blood vessels, helping maintain whatever blood flow remains around the damaged area.⁴ These effects are modest but meaningful when applied across thousands of patients.

The best evidence for early aspirin in ischemic stroke comes from two landmark trials conducted in the 1990s, the International Stroke Trial and the Chinese Acute Stroke Trial, which together enrolled about 40,000 patients. A combined analysis found that aspirin given within 48 hours of an ischemic stroke reduced the risk of another ischemic stroke by about 7 per 1,000 patients and lowered the overall risk of further stroke or death in hospital by about 9 per 1,000.⁵ Those numbers may sound small, but applied across the millions of ischemic strokes that occur worldwide each year, they translate into tens of thousands of prevented deaths and disabilities. The trade-off was an increase of about 2 per 1,000 in hemorrhagic complications, a cost outweighed by the benefit.

The International Stroke Trial on its own showed a similar pattern: patients given aspirin had fewer recurrent ischemic strokes within 14 days compared to those who were not, and the reduction in death or non-fatal recurrent stroke was statistically meaningful.⁶ These trials cemented aspirin’s role as a first-line treatment after confirmed ischemic stroke, but the key word is “confirmed.” Both trials enrolled patients only after brain imaging ruled out hemorrhage.

When Aspirin Gets Paired With a Second Blood Thinner

For people with a minor ischemic stroke or a transient ischemic attack (sometimes called a “mini-stroke”), doctors increasingly use dual antiplatelet therapy, meaning aspirin combined with a second antiplatelet drug like clopidogrel, for a short period. A meta-analysis of randomized trials found that this combination cut the risk of recurrent stroke by about a quarter compared to aspirin alone, though it roughly doubled the risk of major bleeding.⁷ That bleeding risk is why the combination is used only for a limited window, typically 21 to 90 days, and only in minor strokes where the stakes of a recurrent event are high but the baseline bleeding risk is manageable.

A large trial published in the New England Journal of Medicine found that among patients with minor ischemic stroke or high-risk TIA, adding clopidogrel to aspirin reduced major ischemic events from about 6.5% to 5%, with most of the benefit occurring in the first week after the initial event.⁸ A separate trial focused on functional outcomes found that the combination also reduced the rate of disabling stroke at 90 days.⁹ These are decisions made by neurologists after diagnosis, not by bystanders or paramedics in the field. The takeaway for a non-medical reader is that aspirin alone is just the starting point; for certain patients, the hospital team may layer on additional medications tailored to the specific situation.

What Happens When Aspirin Meets a Clot-Busting Drug

If someone arrives at the hospital within a narrow time window after an ischemic stroke, they may receive intravenous thrombolysis, a powerful clot-dissolving drug commonly called tPA. This drug carries its own risk of causing brain bleeding. Giving aspirin on top of tPA within the first 24 hours significantly increases that hemorrhage risk, which is why stroke guidelines specifically recommend holding off on aspirin until at least 24 hours after thrombolytic treatment.¹⁰

This is another reason why giving aspirin before the patient reaches a hospital can backfire. If the person turns out to be eligible for tPA, having aspirin already in their system complicates one of the most time-sensitive and effective treatments available for ischemic stroke. The aspirin you gave in the car or at home cannot be taken back, and it may force doctors to weigh a higher bleeding risk against the benefit of clot dissolution. In select cases, such as patients who also need a mechanical procedure to retrieve a clot, doctors may choose to give antiplatelets earlier, but that is a deliberate clinical judgment made with full imaging and monitoring, not a bystander’s guess.

Stroke Mimics Add Another Layer of Uncertainty

The diagnostic challenge goes beyond hemorrhagic versus ischemic. A significant proportion of people who appear to be having a stroke turn out to have something else entirely. One study found that about 19% of patients initially diagnosed with stroke in the emergency department were eventually found to have a mimic condition, most commonly seizures, infections, brain tumors, or metabolic disturbances.¹¹ Among older adults specifically, about 13% of suspected strokes turned out to be mimics.¹²

For most of these conditions, a single dose of aspirin would be relatively harmless. But some mimics, like a brain tumor with bleeding or an active infection affecting the brain, could be worsened by an antiplatelet drug. More practically, the existence of mimics reinforces why the right response to suspected stroke is getting the person to a hospital, not triaging them at home. The emergency department has the CT scanner, the blood tests, and the neurological expertise to figure out what is actually happening.

If Chewing Aspirin for a Heart Attack Works, Why Not for Stroke?

Many people know that chewing an aspirin tablet is recommended during a suspected heart attack. This creates a reasonable but dangerous intuition: if aspirin helps during a heart attack, it should help during a stroke too. The confusion makes sense because both conditions involve blocked blood vessels, but the critical difference is location and diagnostic certainty. A heart attack is almost always caused by a clot in a coronary artery. There is no “bleeding heart attack” that would be worsened by aspirin. So the calculus is simple: chew the aspirin, get to the hospital. With stroke, the calculus includes a roughly one-in-six chance that the problem is a bleed, and aspirin could make it worse.

Research on aspirin absorption supports the logic behind chewing during a heart attack. A chewed aspirin tablet inhibits half of its target platelet activity in about 5 minutes, compared to about 12 minutes when swallowed whole.¹³ That speed matters in a heart attack, where every minute of continued clotting means more heart muscle dying. In an ischemic stroke, the same speed would also be beneficial, but only if you already know it is ischemic. Since you do not know that without a scan, the faster absorption is irrelevant and could actually accelerate harm in a hemorrhagic scenario.

Difficulty Swallowing After Stroke

Even in the hospital, administering aspirin after a confirmed ischemic stroke is not always straightforward. Stroke frequently impairs the ability to swallow, a condition called dysphagia. Estimates suggest that anywhere from a quarter to 70% of stroke patients develop swallowing difficulties, which substantially raise the risk of choking or inhaling food and liquid into the lungs.¹⁴ This complication is itself linked to a range of downstream problems, including pneumonia.¹⁵

Hospitals routinely screen stroke patients for swallowing problems before giving any oral medication. If a patient cannot safely swallow, aspirin can be given rectally or through a nasogastric tube. A bystander attempting to give someone a tablet during a suspected stroke faces the additional hazard that the person may not be able to swallow it safely, potentially causing choking or aspiration on top of whatever neurological emergency is already underway.

What You Should Actually Do

The steps for responding to a suspected stroke are well-established and worth committing to memory. Call emergency services immediately. Note the time symptoms started, because this information is critical for treatment decisions at the hospital. Keep the person comfortable, ideally lying on their side to protect their airway if they vomit or lose consciousness. Do not give them anything to eat or drink, including aspirin. Do not drive them to the hospital yourself if an ambulance can reach you reasonably quickly, because paramedics can begin assessment and alert the stroke team en route.

Some regions now deploy mobile stroke units, which are ambulances equipped with portable CT scanners and staffed by neurologists or specially trained paramedics. These units can perform brain imaging in the field and start clot-dissolving treatment before the patient reaches the hospital. Three recent clinical trials have shown that management in a mobile stroke unit improves outcomes for eligible patients, largely because treatment starts sooner.¹⁶ If this technology is available in your area, dispatchers will send it when stroke is suspected. Your job as a bystander is the same regardless: call for help, share the timeline, and keep the person safe until professionals arrive.

Aspirin’s Role After the Acute Phase

Once a patient has survived an ischemic stroke and the immediate crisis has passed, aspirin typically becomes part of a long-term prevention plan. A meta-analysis of 11 randomized trials found that daily aspirin reduced the combined risk of recurrent stroke, heart attack, and vascular death by about 13%.¹⁷ There is an interesting wrinkle in dosing: studies comparing low-dose aspirin (around 75 to 100 mg daily) with much higher doses found no difference in how well they prevent recurrent strokes, but gastrointestinal side effects and bleeding complications climb steeply above 150 mg per day. Most guidelines now recommend the lower dose range.

Aspirin is not the only option for long-term prevention. Network meta-analyses comparing various antiplatelet regimens have found that some alternatives perform comparably or slightly better in specific populations, with varying bleeding profiles.¹⁸ The combination of aspirin and clopidogrel, for instance, was associated with significantly more bleeding events than other regimens in the long term, which is why it is reserved for short-duration use rather than indefinite prevention. The choice of long-term antiplatelet therapy depends on the individual patient’s stroke type, risk factors, and tolerance for side effects.

The Statistical Safety Net That Exists but Should Not Comfort You

One counterargument occasionally surfaces in medical literature: since about 83% of strokes are ischemic, the overall risk of giving aspirin blindly is relatively low. A Dutch study calculated that the excess risk of bad outcomes from skipping the CT scan and giving aspirin to all stroke patients was on average only about 0.6% over two years.¹⁹ That number reflects a population-level calculation: across all patients, the benefit aspirin provides to the ischemic majority slightly outweighs the harm it causes to the hemorrhagic minority.

But this framing is misleading for a bystander making a decision about one person. If the person in front of you happens to be in the hemorrhagic minority, a 0.6% population average is cold comfort. The person does not experience a statistical average; they experience the full impact of worsened bleeding in their brain. Population-level net benefit is useful for policy makers deciding whether to stock aspirin on ambulances in regions without CT access. It is not useful for deciding whether you should hand a tablet to your father on the living room floor. The asymmetry of consequences matters: the benefit aspirin provides in an ischemic stroke is modest, while the harm it can cause in a hemorrhagic stroke can be catastrophic. When brain imaging is available within hours, as it is in most developed healthcare systems, there is no reason to skip it.

When the Hospital Does Not Have a CT Scanner

In resource-limited settings, particularly in lower-income countries and remote rural areas, the calculation can look different. If brain imaging is not available and will not be available within a reasonable time frame, clinicians sometimes face the decision of whether to start aspirin based on clinical judgment alone. The population-level statistics described above become more relevant in these settings, because the alternative is no acute treatment at all. Some clinical protocols in these environments do permit aspirin for suspected stroke when imaging is truly inaccessible, accepting the small population-level excess risk as preferable to withholding all treatment from the ischemic majority.

This does not apply to most readers of this article. If you have access to emergency medical services and a hospital with a CT scanner, the answer remains clear: do not give aspirin for suspected stroke. Call for help, get the person to a scanner, and let the medical team decide. The time lost waiting for imaging is far less costly than the potential harm of guessing wrong.